Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Liabilities and Shareholders Equity (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Liabilities and Shareholders Equity for 7 consecutive years, with $92.1 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 21.01% to $92.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $382.3 million through Dec 2025, up 119.0% year-over-year, with the annual reading at $92.1 million for FY2025, 21.01% up from the prior year.
  • Liabilities and Shareholders Equity hit $92.1 million in Q4 2025 for Eton Pharmaceuticals, down from $104.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $104.5 million in Q3 2025 to a low of $21.5 million in Q3 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $44.1 million across 5 years, with a median of $31.1 million in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 25.62% in 2022 and later soared 219.5% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $27.5 million in 2021, then fell by 8.87% to $25.0 million in 2022, then grew by 26.81% to $31.7 million in 2023, then skyrocketed by 139.83% to $76.1 million in 2024, then grew by 21.01% to $92.1 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ETON at $92.1 million in Q4 2025, $104.5 million in Q3 2025, and $101.7 million in Q2 2025.